Current role
Tanya Sengupta
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Tanya Sengupta
Crescent Biopharma, Inc. reported in an 8-K filed July 31, 2025 that Tanya Sengupta was appointed executive vice president, chief of strategy and operations.
“Crescent appointed new leadership bringing experience in oncology drug development, clinical operations and building biotech companies, including Joshua Brumm as chief executive officer and member of the board of directors; Jonathan McNeill, M.D., as president and chief operating officer; Ellie Im, M.D., as chief medical officer; Rick Scalzo, MBA, as chief financial officer; Jan Pinkas, Ph.D., as chief scientific officer; Amy Reilly as chief communications officer; and Tanya Sengupta, MBA, as executive vice president, chief of strategy and operations.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Crescent Biopharma, Inc. (CBIO)
SEC 8-K
Current2025-07-31–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Crescent Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Joshua Brumm CEO, Board Member
- Peter Harwin Chairman, Board Member
- Richard Scalzo CFO
- Rick Scalzo CFO
- Jonathan McNeill COO
- Barbara Bispham General Counsel
- Barbara Bispham Hale General Counsel
- Ryan Lynch Chief Accounting Officer
- Alexandra Balcom Board Member
- David Lubner Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.